CH376123A - Verfahren zur Herstellung von neuen Thiocolchicin-Derivaten - Google Patents
Verfahren zur Herstellung von neuen Thiocolchicin-DerivatenInfo
- Publication number
- CH376123A CH376123A CH7650359A CH7650359A CH376123A CH 376123 A CH376123 A CH 376123A CH 7650359 A CH7650359 A CH 7650359A CH 7650359 A CH7650359 A CH 7650359A CH 376123 A CH376123 A CH 376123A
- Authority
- CH
- Switzerland
- Prior art keywords
- carboxylic acid
- derivatives
- preparation
- new
- derivative
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 4
- CMEGANPVAXDBPL-INIZCTEOSA-N n-[(7s)-1,2,3-trimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5h-benzo[a]heptalen-7-yl]acetamide Chemical class C1([C@@H](NC(C)=O)CC2)=CC(=O)C(SC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC CMEGANPVAXDBPL-INIZCTEOSA-N 0.000 title description 3
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- HFPMXDMZJUJZBX-AWEZNQCLSA-N Deacetylcolchicine Chemical class C1([C@@H](N)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC HFPMXDMZJUJZBX-AWEZNQCLSA-N 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 6
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical class C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 5
- 101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- OMIHGPLIXGGMJB-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]hepta-1,3,5-triene Chemical compound C1=CC=C2OC2=C1 OMIHGPLIXGGMJB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- SJSOFNCYXJUNBT-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1OC SJSOFNCYXJUNBT-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000031864 metaphase Effects 0.000 description 2
- -1 nausea Chemical compound 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NUNCOHUMTCDISK-AWEZNQCLSA-N (7s)-7-amino-1,2,3-trimethoxy-10-methylsulfanyl-6,7-dihydro-5h-benzo[a]heptalen-9-one Chemical compound C1([C@@H](N)CC2)=CC(=O)C(SC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC NUNCOHUMTCDISK-AWEZNQCLSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000003468 Ehrlich Tumor Carcinoma Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940045695 antineooplastic colchicine derivative Drugs 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- IPIVAXLHTVNRBS-UHFFFAOYSA-N decanoyl chloride Chemical compound CCCCCCCCCC(Cl)=O IPIVAXLHTVNRBS-UHFFFAOYSA-N 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- NQGIJDNPUZEBRU-UHFFFAOYSA-N dodecanoyl chloride Chemical compound CCCCCCCCCCCC(Cl)=O NQGIJDNPUZEBRU-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical compound CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- NTQYXUJLILNTFH-UHFFFAOYSA-N nonanoyl chloride Chemical compound CCCCCCCCC(Cl)=O NTQYXUJLILNTFH-UHFFFAOYSA-N 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- JUKPJGZUFHCZQI-UHFFFAOYSA-N undecanoyl chloride Chemical compound CCCCCCCCCCC(Cl)=O JUKPJGZUFHCZQI-UHFFFAOYSA-N 0.000 description 1
- 125000000297 undecanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7650359A CH376123A (de) | 1959-08-03 | 1959-08-03 | Verfahren zur Herstellung von neuen Thiocolchicin-Derivaten |
| GB2579860A GB934193A (en) | 1959-08-03 | 1960-07-25 | Improvements in or relating to thiocolchicine compounds |
| LU39030D LU39030A1 (en(2012)) | 1959-08-03 | 1960-08-01 | |
| ES0260062A ES260062A1 (es) | 1959-08-03 | 1960-08-01 | Procedimiento de obtencion de derivados de tiocolchicina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7650359A CH376123A (de) | 1959-08-03 | 1959-08-03 | Verfahren zur Herstellung von neuen Thiocolchicin-Derivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH376123A true CH376123A (de) | 1964-03-31 |
Family
ID=4534978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH7650359A CH376123A (de) | 1959-08-03 | 1959-08-03 | Verfahren zur Herstellung von neuen Thiocolchicin-Derivaten |
Country Status (4)
| Country | Link |
|---|---|
| CH (1) | CH376123A (en(2012)) |
| ES (1) | ES260062A1 (en(2012)) |
| GB (1) | GB934193A (en(2012)) |
| LU (1) | LU39030A1 (en(2012)) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6825236B2 (en) * | 2003-04-14 | 2004-11-30 | California Pacific Medical Center | Colchicine derivatives |
-
1959
- 1959-08-03 CH CH7650359A patent/CH376123A/de unknown
-
1960
- 1960-07-25 GB GB2579860A patent/GB934193A/en not_active Expired
- 1960-08-01 LU LU39030D patent/LU39030A1/xx unknown
- 1960-08-01 ES ES0260062A patent/ES260062A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB934193A (en) | 1963-08-14 |
| LU39030A1 (en(2012)) | 1961-02-01 |
| ES260062A1 (es) | 1961-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2824905A1 (de) | Neue 1, 2, 3, 4, 6, 7-hexahydro-11 balphah-benzo(a)chinolizin-derivate und verfahren zur herstellung derselben | |
| DE2802023A1 (de) | Neue ergotderivate, ihre herstellung und verwendung | |
| CH376123A (de) | Verfahren zur Herstellung von neuen Thiocolchicin-Derivaten | |
| DE2223681A1 (de) | Neue heterocyclische Verbindungen und Verfahren zu ihrer Herstellung | |
| DE2525962A1 (de) | Neue heterocyclische verbindungen, ihre herstellung und verwendung | |
| CH497413A (de) | Verfahren zur Herstellung von Acylderivaten des Proscillaridins A | |
| DE1041038B (de) | Verfahren zur Herstellung von wenig toxischen Salzen von basischen Streptomyces-Antibiotika | |
| CH391694A (de) | Verfahren zur Herstellung von neuen Thiocolchicin-Derivaten | |
| AT228943B (de) | Verfahren zur Herstellung von neuen acylierten N-Desacetylthiocolchicinen | |
| AT243990B (de) | Verfahren zur Herstellung von neuen, am Indolstickstoff substituierten Amiden der Lysergsäure und der Dihydrolysergsäure | |
| DE2833442C2 (de) | Verfahren zur Herstellung von 7β-Amino-7α-Methoxycephalosporansäurederivaten | |
| AT203491B (de) | Verfahren zur Herstellung von neuen 3,5-Diketo-pyrazolidin-Derivaten | |
| AT264722B (de) | Verfahren zur Herstellung von neuen alicyclischen Verbindungen | |
| AT339292B (de) | Verfahren zur herstellung von neuen substituierten alfa-aminooxyhydroxamsaurederivaten | |
| DE860494C (de) | Verfahren zur Darstellung von Urethanen mit dem Ringsystem der Lysergsaeure am Stickstoff | |
| AT228409B (de) | Verfahren zur Herstellung von neuen Lysergsäuren | |
| AT354647B (de) | Verfahren zur herstellung eines neuen 6-methyl- 8-(substituierten)methylergolins und seiner saeureadditionssalze | |
| AT205661B (de) | Verfahren zur Herstellung von Estern der Penicilline G und X | |
| CH374645A (de) | Verfahren zur Herstellung von neuen Thiocolchicin-Derivaten | |
| CH602766A5 (en) | 10-Alpha-methoxy-di:hydro-beta-ergosine derivs. | |
| AT277474B (de) | Verfahren zur Herstellung neuer Derivate von Bufadienolidglykosiden | |
| AT201245B (de) | Verfahren zur Herstellung von neuen am Indolstickstoff substituierten Derivaten der Lysergsäuren-Reihe | |
| AT214448B (de) | Verfahren zur Herstellung des neuen 10-(N-β-Hydroxyäthyl-piperazinyl-N'-propyl)-2-chlor-phenothiazin-5-oxyds | |
| CH640860A5 (de) | Verfahren zur herstellung von rifamycin-derivaten, solche derivate und deren verwendung. | |
| CH410287A (de) | Verfahren zur Herstellung neuer Antibiotika |